Adicet Bio
ACET
#10726
Rank
NZ$36.54 M
Marketcap
NZ$3.90
Share price
-13.01%
Change (1 day)
276.40%
Change (1 year)

Earnings for Adicet Bio (ACET)

Earnings in 2026 (TTM): -NZ$0.18 Billion

According to Adicet Bio's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.22 Billion, an increase over its 2024 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adicet Bio from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.18 Billion-19.52%
2025 -NZ$0.22 Billion-0.3%
2024 -NZ$0.22 Billion-17.89%
2023 -NZ$0.27 Billion104.61%
2022 -NZ$0.13 Billion12.53%
2021 -NZ$0.12 Billion57.39%
2020 -NZ$71.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$23.06 B-12,903.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.71 B-7,156.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.26 B-6,908.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.23 B-1,339.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
NZ$0.21 B-217.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
NZ$0.28 B-255.53%๐Ÿ‡บ๐Ÿ‡ธ USA